glutathione parkinson NAD IV Therapy and IV for Parkinson's Disease Glutathione IV Therapy | The

Disclosure of interest: Nothing to disclose for all authors Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.05 - NEUROINTERVENTION P674 - ESOC25-632 IMPACT OF HEMISPHERE ON EVT FOR LARGE ISCHEMIC CORE LVO PATIENTS Manabu Sihrakawa 1 , Kazutaka Uchida 1 , Fumihiro Sakakibara 1 , Hiroshi Yamagami 2 , Nobuyuki Sakai 3 , Takeshi Morimoro 4 , Shinichi Yoshimura 1 1 Hyogo medical University, Nishinomiya, Japan, 2 University of Tsukuba, Tsukuba, Japan, 3 Shimizu hospital, Kyoto, Japan, 4 Hyogo Medical University, Nishinomiya, Japan Background and Aims: Hemispheric differences may influence stroke outcomes

Lyophilized powder should be stored at -20C

Furthermore, IM administration of hydroxocobalamin is also the preferred treatment for pediatric patients with intrinsic cobalamin metabolic diseases

58,59 Overall, the future research direction of GLP-1RAs involves making them more similar to those in the human body, extending their duration of action, and creating oral formulations for easier administration

Cross-trial numbers suggest all are potent, but they come from separate studies with different populations and designs, and there are few direct head-to-head trials, so relative rankings remain uncertain